Retinal Vein Occlusion (Eye Stroke): Symptoms, Causes, Diagnosis, and Treatment Options
Understanding Retinal Vein Occlusion
A retinal vein occlusion, sometimes called an eye stroke, occurs when a blood vessel that carries blood away from the retina becomes blocked, causing sudden changes in vision. This condition is one of the most common retinal vascular disorders and can range from mild to sight-threatening depending on the location and severity of the blockage. According to the American Academy of Ophthalmology, retinal vein occlusion is the second most common retinal vascular disease after diabetic retinopathy, affecting an estimated 16 million people worldwide (AAO). At Greenwich Ophthalmology Associates, our fellowship-trained retina specialists in the greater NY/CT region use advanced diagnostic imaging and proven treatment protocols to help preserve your vision after a retinal vein occlusion. Understanding the warning signs and seeking a timely evaluation are essential steps toward protecting your eyesight.
The retina is the thin layer of light-sensitive tissue lining the back of the eye that converts visual information into signals the brain interprets as sight. It depends on a constant supply of oxygen-rich blood delivered by arteries and carried away by veins. When a retinal vein is obstructed, blood cannot drain properly, and pressure builds within the surrounding smaller blood vessels.
In most cases, a retinal vein occlusion forms when a nearby artery that has become thickened or hardened compresses the vein where they share a common outer covering. This compression slows blood flow and can trigger a clot that blocks the vein. The resulting backup of blood causes hemorrhages, swelling, and fluid leakage within the retina, which can damage the photoreceptor cells responsible for clear vision.
There are two main types. A branch retinal vein occlusion (BRVO) affects one of the smaller branch veins and typically involves only a portion of the retina. A central retinal vein occlusion (CRVO) involves the main retinal vein where all branch veins converge, affecting a larger area and generally carrying a greater risk of significant vision loss. Both types can range from mild to severe depending on the degree of macular swelling and ischemia (reduced blood supply to the retina).
What Causes a Retinal Vein Occlusion
Retinal vein occlusion results from a combination of structural changes within the eye's blood vessels and broader systemic health factors. The most common mechanism involves atherosclerosis, a condition in which artery walls gradually thicken and lose flexibility. Retinal arteries and veins frequently cross paths inside the eye, sharing a thin connective tissue sheath at those intersections. When an artery stiffens from atherosclerosis, it can compress the adjacent vein, narrowing it enough to slow blood flow and promote clot formation.
Conditions that increase the tendency for blood to clot can contribute to retinal vein occlusion. These include dehydration, certain blood disorders such as polycythemia (an elevated red blood cell count), and inherited clotting conditions like Factor V Leiden mutation. Inflammation within blood vessel walls can also damage the inner lining of the vein and encourage clot development.
Several systemic conditions raise the likelihood of developing a retinal vein occlusion. High blood pressure is the most commonly associated risk factor, followed by diabetes, high cholesterol, and cardiovascular disease. Glaucoma and elevated intraocular pressure also increase risk by compressing veins as they exit through the optic nerve head. Patients diagnosed with a retinal vein occlusion often benefit from a thorough medical workup to identify and treat these contributing conditions.
Symptoms of a Retinal Vein Occlusion
Symptoms of a retinal vein occlusion typically appear suddenly in one eye, and early recognition can play an important role in treatment outcomes. Most people notice a rapid, painless decrease in vision in one eye. The change can occur over a few hours or develop overnight. Unlike conditions that cause eye pain or redness, retinal vein occlusion usually affects vision without any accompanying discomfort, which sometimes leads patients to delay seeking care.
When the blockage causes fluid to accumulate in the macula, the central area of the retina responsible for detailed vision, patients often experience blurriness, distorted straight lines, or a dark area in their central visual field. In branch vein occlusions, the affected zone may correspond to only one portion of the visual field, while central occlusions tend to reduce overall clarity more broadly.
Some patients report a sudden increase in floaters or dark spots drifting through their vision. These can result from small hemorrhages that release blood into the vitreous, the gel-like substance filling the eye's interior. A sudden shower of new floaters, particularly when combined with blurred vision, warrants prompt evaluation.
Any sudden, unexplained change in vision should be evaluated as quickly as possible. Like other urgent eye conditions such as retinal detachment and corneal laceration, a retinal vein occlusion benefits from early diagnosis so that treatment can begin before permanent damage occurs. If you notice sudden vision loss, new distortion, or a dramatic increase in floaters in one eye, contact our ophthalmologists right away.
How Retinal Vein Occlusion Is Diagnosed
A thorough clinical examination combined with advanced imaging allows our retina specialists to confirm the diagnosis, determine the type and severity of the occlusion, and guide treatment decisions. The diagnostic process begins with a comprehensive dilated eye examination, during which your doctor uses specialized lenses to view the retina directly. Characteristic findings include flame-shaped hemorrhages (bleeding that follows the pattern of retinal nerve fibers), cotton-wool spots (small white patches caused by localized ischemia), and dilated, engorged veins. The distribution of these findings helps distinguish between a branch and central occlusion.
Optical coherence tomography, or OCT, is a noninvasive scan that produces detailed cross-sectional images of the retina. It measures macular edema (swelling in the central retina) with high precision and is essential for tracking how the retina responds to treatment over time. OCT can reveal fluid accumulation that may not be apparent during a standard examination, making it one of the most important tools in managing this condition.
Fluorescein angiography involves injecting a fluorescent dye into a vein in the arm and photographing the dye as it circulates through the retinal blood vessels. This test highlights areas of blockage, leakage, and poor blood flow, and it identifies whether abnormal new blood vessels have begun to form. The results help determine whether laser treatment or other additional interventions are needed.
Because retinal vein occlusion is closely linked to systemic health conditions, we often recommend blood work to evaluate blood pressure control, blood sugar levels, cholesterol, and clotting factors. In younger patients or those without typical risk factors, additional testing for inflammatory or autoimmune conditions may be appropriate. Coordinating with your primary care physician ensures that all contributing health factors are addressed alongside your eye care.
How Retinal Vein Occlusion Is Treated
Treatment focuses on reducing macular swelling, preventing complications such as abnormal blood vessel growth, and preserving as much vision as possible. Anti-VEGF (vascular endothelial growth factor) injections are the primary treatment for macular edema caused by retinal vein occlusion. Medications including ranibizumab, aflibercept, and the newer bispecific antibody faricimab work by blocking the protein responsible for fluid leakage and abnormal blood vessel growth. These injections are administered directly into the eye in a comfortable office setting with numbing drops applied beforehand. Most patients start with a series of monthly injections, and our retina specialists adjust the ongoing schedule based on how your retina responds.
For patients who do not respond adequately to anti-VEGF therapy, or for whom frequent monthly visits are challenging, intravitreal corticosteroid implants provide an alternative approach. A dexamethasone implant slowly releases anti-inflammatory medication inside the eye over several months, reducing swelling effectively. Because corticosteroids carry a higher risk of elevated eye pressure and cataract progression, our team evaluates each patient's circumstances carefully before recommending this option.
Laser treatment may be recommended when a retinal vein occlusion leads to neovascularization, the growth of fragile abnormal blood vessels on the retina or iris. Panretinal photocoagulation targets ischemic areas of the retina, reducing oxygen demand and removing the stimulus for new vessel growth. While anti-VEGF injections have become the preferred first-line therapy for macular edema, laser treatment remains an important tool for managing neovascular complications and is sometimes used in combination with injections.
Retinal vein occlusion typically requires long-term follow-up because macular edema can recur and complications may develop months after the initial event. Regular OCT scans and clinical examinations allow us to detect changes early and adjust treatment as needed. Managing underlying conditions such as blood pressure and blood sugar remains an equally important part of the overall care plan and can influence long-term visual outcomes.
Frequently Asked Questions
A branch retinal vein occlusion (BRVO) blocks one of the smaller veins draining a section of the retina, while a central retinal vein occlusion (CRVO) blocks the main vein that collects blood from the entire retina. BRVO generally carries a better prognosis, with over 60% of patients maintaining 20/40 vision or better after one year. CRVO tends to cause more widespread retinal damage and often requires more intensive treatment, though meaningful vision improvements are still achievable with timely care.
Many patients experience significant improvement with prompt anti-VEGF treatment. Long-term studies show that nearly 40% of treated eyes gain 15 or more letters on a standard vision chart over five years, and over 80% avoid moderate vision loss. The degree of recovery depends on the severity and type of occlusion, the extent of retinal ischemia, and how quickly treatment begins. Our retina specialists develop a personalized plan to give your eye the best opportunity for recovery.
High blood pressure is the leading risk factor, followed by diabetes, high cholesterol, cardiovascular disease, and glaucoma. The condition becomes more common after age 50, and smoking and obesity further increase susceptibility. Certain inherited blood clotting disorders can also play a role. Working with your eye doctor and primary care physician to manage these factors can reduce the risk of recurrence in either eye.
Yes. Chronic macular edema is the most common complication and the primary driver of ongoing vision loss. In severe ischemic cases, the retina may grow abnormal new blood vessels on the iris or retinal surface, which can bleed into the vitreous or block the eye's drainage system, potentially leading to conditions such as hyphema or neovascular glaucoma. Consistent follow-up is essential to detect these developments early, even when initial treatment has been successful.
There is no guaranteed way to prevent a retinal vein occlusion, but managing the conditions that contribute to it significantly lowers your risk. Keeping blood pressure, blood sugar, and cholesterol well controlled are the most impactful steps you can take. Regular comprehensive eye examinations help detect early vascular changes before they progress. Staying physically active, maintaining a healthy weight, and not smoking also support vascular health throughout the body.
A retinal vein occlusion shares many of the same underlying risk factors as a stroke or heart attack, including atherosclerosis, high blood pressure, and diabetes. While an eye stroke does not directly cause a cerebral stroke, its occurrence can serve as an important signal that your cardiovascular risk factors need closer attention. Studies suggest a modestly increased risk of future cardiovascular events in patients with retinal vein occlusion, which is why we emphasize coordinating with your primary care physician for a complete vascular health evaluation.
What our Patients say
4.8
Reviews
(3,408)